Masanobu Horie

Dr. Masanobu Horie

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2022 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
MHMasanobu Horie
Masanobu Horie
NYNoriko Yamano-Adachi
Noriko Yamano-Adachi
YKYoshinori Kawabe
Yoshinori Kawabe
HKHidenori Kaneoke
Hidenori Kaneoke
HFHideaki Fujita
Hideaki Fujita
Kosuke InoKosuke Ino
Kosuke Ino

19 January 2023 in Genes
Verified
Journal Article
Open access
PDF file
HFHideaki Fujita
Hideaki Fujita
SOSeiichi Ohta
Seiichi Ohta
NNNoriko Nakamura
Noriko Nakamura
MSMasaharu Somiya
Masaharu Somiya
MHMasanobu Horie
Masanobu Horie
The focus of this brief review is to describe the application of nanoparticles, including endogenous nanoparticles (e.g., extracellular vesicles, EVs, and virus capsids) and exogenous nanoparticles (e.g., organic and inorganic materials) in cancer therapy and diagnostics. In this review, we mainly focused on EVs, where a recent study demonstrated that EVs secreted from cancer cells are associated with malignant alterations in cancer. EVs are expected to be used for cancer diagnostics by analyzing their informative cargo. Exogenous nanoparticles are also used in cancer diagnostics as imaging probes because they can be easily functionalized. Nanoparticles are promising targets for drug delivery system (DDS) development and have recently been actively studied. In this review, we introduce nanoparticles as a powerful tool in the field of cancer therapy and diagnostics and discuss issues and future prospects.

6 July 2023 in Cancer Science
Verified
Journal Article
Open access
KKKaneko Kaneko
Kaneko Kaneko
HYHiroto Yamazaki
Hiroto Yamazaki
TOTakahiro Ono
Takahiro Ono
MHMasanobu Horie
Masanobu Horie
AIAkira Ito
Akira Ito
Magnetic hyperthermia (MHT) is a promising cancer treatment because tumor tissue can be specifically damaged by utilizing the heat generated by nano‐heaters such as magnetite nanoparticles (MNPs) under an alternating magnetic field. MNPs are taken up by cancer cells, enabling intracellular MHT. Subcellular localization of MNPs can affect the efficiency of intracellular MHT. In this study, we attempted to improve the therapeutic efficacy of MHT by using mitochondria‐targeting MNPs. Mitochondria‐targeting MNPs were prepared by the modification of carboxyl phospholipid polymers containing triphenylphosphonium (TPP) moieties that accumulate in mitochondria. The mitochondrial localization of polymer‐modified MNPs was supported by transmission electron microscopy observations of murine colon cancer CT26 cells treated with polymer‐modified MNPs. In vitro and in vivo MHT using polymer‐modified MNPs revealed that the therapeutic effects were enhanced by introducing TPP. Our results indicate the validity of mitochondria targeting in enhancing the therapeutic outcome of MHT. These findings will pave the way for developing a new strategy for the surface design of MNPs and therapeutic strategies for MHT.

1 July 2020 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
RDRan Ding
Ran Ding
MHMasanobu Horie
Masanobu Horie
SNSumire Nagasaka
Sumire Nagasaka
SOSaki Ohsumi
Saki Ohsumi
KSKazunori Shimizu
Kazunori Shimizu
TKTakuo Kawamoto
Takuo Kawamoto

27 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
KYKantaro Yoshioka
Kantaro Yoshioka
AIAkira Ito
Akira Ito
MHMasanobu Horie
Masanobu Horie
KIKazushi Ikeda
Kazushi Ikeda
SKSho Kataoka
Sho Kataoka
Masamichi KamihiraMasamichi Kamihira
Masamichi Kamihira
Duchenne muscular dystrophy (DMD) is a genetic disorder that results from deficiency of the dystrophin protein. In recent years, DMD pathological models have been created using induced pluripotent stem (iPS) cells derived from DMD patients. In addition, gene therapy using CRISPR-Cas9 technology to repair the dystrophin gene has been proposed as a new treatment method for DMD. However, it is not known whether the contractile function of myotubes derived from gene-repaired iPS cells can be restored. We therefore investigated the maturation of myotubes in electrical pulse stimulation culture and examined the effect of gene repair by observing the contractile behaviour of myotubes. The contraction activity of myotubes derived from dystrophin-gene repaired iPS cells was improved by electrical pulse stimulation culture. The iPS cell method used in this study for evaluating muscle contractile activity is a useful technique for analysing the mechanism of hereditary muscular disease pathogenesis and for evaluating the efficacy of new drugs and gene therapy.

26 January 2017
Verified
Book Chapter
Closed access
PDF file
MHMasanobu Horie
Masanobu Horie
ATAnuj Tripathi
Anuj Tripathi
AIAkira Ito
Akira Ito
YKYoshinori Kawabe
Yoshinori Kawabe
Masamichi KamihiraMasamichi Kamihira
Masamichi Kamihira